Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02498613
Title A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
Recruitment Active, not recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung small cell carcinoma

triple-receptor negative breast cancer

lung non-small cell carcinoma

pancreatic adenocarcinoma

Therapies

Cediranib + Olaparib

Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
UC San Diego Medical Center - Hillcrest San Diego California 92103 United States Details
UCSF Medical Center-Mount Zion San Francisco California 94115 United States Details
Smilow Cancer Center/Yale-New Haven Hospital New Haven Connecticut 06510 United States Details
Yale University New Haven Connecticut 06520 United States Details
Moffitt Cancer Center-International Plaza Tampa Florida 33607 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 United States Details
BCCA-Vancouver Cancer Centre Vancouver British Columbia V5Z 4E6 Canada Details
University Health Network-Princess Margaret Hospital Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field